In vitro study to assess the efficacy of CDK4/6 inhibitor Palbociclib (PD‐0332991) for treating canine mammary tumours

著录项

• 来源
  《Veterinary and Comparative Oncology》 |2019年第4期|共15页
• 作者

  Schoos Alexandra; Knab Vanessa M.; Gabriel Cordula; Tripolt Sabrina; Wagner Daniela A.; Bauder Barbara; Url Angelika; Fux Daniela A.;

  展开▼
• 作者单位

  Institute of Pharmacology and Toxicology Unit of Clinical PharmacologyUniversity of Veterinary MedicineVienna Austria;

  Institute of Pharmacology and Toxicology Unit of Clinical PharmacologyUniversity of Veterinary MedicineVienna Austria;

  Institute of Pathology and Forensic Veterinary MedicineUniversity of Veterinary MedicineVienna Austria;

  Institute of Pharmacology and Toxicology Unit of Clinical PharmacologyUniversity of Veterinary MedicineVienna Austria;

  Institute of Pharmacology and Toxicology Unit of Clinical PharmacologyUniversity of Veterinary MedicineVienna Austria;

  Institute of Pathology and Forensic Veterinary MedicineUniversity of Veterinary MedicineVienna Austria;

  Institute of Pathology and Forensic Veterinary MedicineUniversity of Veterinary MedicineVienna Austria;

  Institute of Pharmacology and Toxicology Unit of Clinical PharmacologyUniversity of Veterinary MedicineVienna Austria;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 动物医学（兽医学）;
• 关键词

  canine mammary tumour; CDK4/6; cell cycle; migration; Palbociclib;

  机译：犬乳腺肿瘤;CDK4 / 6;细胞周期;迁移;帕尔博克;